The company
Vor Biopharma Inc.
VOR · Nasdaq
VOR stood above a rising 150-day average in 16 of the last 52 weekly readings, including each of the last 15 weeks. It is 0.4% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 15 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $119.2M
- Officials’ trades on record
- 0
- Institutions holding
- 100 (+22)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Ra Capital Management, L.p.10% owner | sold | 213at $19.75 | 16 Jul 2026filed 21 Jul 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 165,150at $15.77 | 22 Apr 2026filed 24 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 171,963at $15.77 | 20 Apr 2026filed 21 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 458,411at $16.28 | 17 Apr 2026filed 21 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 53,644at $16.01 | 15 Apr 2026filed 15 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 153,735at $15.97 | 14 Apr 2026filed 15 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 530,610at $16.15 | 13 Apr 2026filed 15 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 828at $15.75 | 10 Apr 2026filed 10 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 135,201at $16.59 | 9 Apr 2026filed 10 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 353,242at $16.32 | 8 Apr 2026filed 10 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 130,862at $16.91 | 8 Apr 2026filed 10 Apr 2026 |
| Ra Capital Management, L.p.Director, 10% owner | sold | 537,754at $16.51 | 6 Apr 2026filed 6 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| TCG Crossover Management, LLCunchanged · filed 14 Aug 2026 | 5,673,078$104.4M | 00.0% |
| FMR LLCadded · filed 13 Aug 2026 | 4,932,149$90.8M | +3,392,479+220.3% |
| FCPM III SERVICES B.V.unchanged · filed 14 Aug 2026 | 4,117,354$75.8M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 3,468,107$63.8M | +2,673,348+336.4% |
| Venrock Adviser, LLCunchanged · filed 14 Aug 2026 | 3,041,719$56.0M | 00.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,616,336$48.2M | +1,497,878+133.9% |
| Frazier Life Sciences Management, L.P.unchanged · filed 14 Aug 2026 | 2,543,939$46.8M | 00.0% |
| RA CAPITAL MANAGEMENT, L.P.reduced · filed 14 Aug 2026 | 2,402,095$44.2M | -3,002,903−55.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,084,328$38.4M | +651,048+45.4% |
| Caligan Partners LPunchanged · filed 14 Aug 2026 | 1,925,066$35.4M | 00.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.